Novel aminopyridine derivatives as mglur5 antagonists

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 213/73 (2006.01) A61K 31/44 (2006.01) A61K 31/444 (2006.01) A61P 25/00 (2006.01) C07D 213/74 (2006.01)

Patent

CA 2517083

The invention relates to novel aminopyridine derivatives of formula (I) wherein R1 is methyl an R4 and amino group NR6R7 and R5 forms an arylalkynyl- or heteroarylalkynyl-group. The compounds are useful in the prevention or treatment of central nervous system disorders as well as other disorders modulated by mGIuR5 receptors.

L'invention concerne de nouveaux dérivés d'aminopyridine de formule (I), dans laquelle R1 représente méthyle et R4 un groupe amine, NR¿6?R¿7? et R¿5? formant un groupement arylalkynyle ou hétéroarylalkynyle. Ces composés sont utiles pour prévenir ou traiter des troubles du système nerveux central et d'autres troubles modulés par des récepteurs de mGluR5.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Novel aminopyridine derivatives as mglur5 antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel aminopyridine derivatives as mglur5 antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel aminopyridine derivatives as mglur5 antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1477528

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.